Does lymphedema following breast cancer warrant clinical attention?
Hayes, Sandra C. & Newman, Beth M. (2009) Does lymphedema following breast cancer warrant clinical attention? The American Journal of Hematology/Oncology, 8(1), pp. 39-40.
![[img]](http://eprints.qut.edu.au/style/images/fileicons/application_pdf.png) | Pending publisher's permission (PDF 192kB) Published Version. Administrators only | Request a copy from author |
Abstract
Secondary lymphedema (swelling) after breast cancer treatment usually develops on the hand, arm, shoulder, and/or breast on the treated side. It is commonly associated
with the presence of other upper-body symptoms, such as
pain and aching1; it impacts physical and psychosocial functioning and adversely influences quality of life.2 Moreover, it is considered incurable, progressive, and difficult to treat. Arguably, lymphedema is the most problematic and dreaded treatment-related complication of
breast cancer.3
Citations:
Citation countsare sourced monthly from Scopus and Web of Science citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science generally from 1980 onwards.
Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.
Export: EndNote | Dublin Core | BibTeX
Repository Staff Only: item control page